Editorial Board About Us

Helen Sadri

All articles from this author are listed below.

Volume 11, Number 3 Review Articles

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials

Management Update

Markus Margreiter Helen Sadri Julia Finkelstein Elisabeth Eckersberger Bob Djavan Samir S Taneja Herbert Lepor

The advent of prostate-specific antigen (PSA) testing in the early 1980srevolutionized the diagnosis of prostate cancer. As a result of PSA testing,there has been a surge in the number of prostate cancer diagnoses. Thisreview examines the results of 2 recent landmark trials that studied the effectof screening on prostate cancer mortality: the European Randomized Study ofScreening for Prostate Cancer (ERSPC) and the US-based Prostate, Lung,Colorectal, and Ovarian (PLCO) Cancer Screening Trial.[Rev Urol. 2009;11(3):127-133 doi: 10.3909/riu0474]

PSA screening European Randomized Study of Screening for Prostate Cancer(ERSPC)Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Volume 12, Number 3 Meeting Reviews

Uro-Oncological Controversies in Euro-Oncology

Meeting Review

Elisabeth Eckersberger Mike Harik Markus Margreiter Helen Sadri Alexander Farr Bob Djavan Herbert Lepor

Highlights From the European Association of Urology Section of Oncological Urology, January 15-17, 2010, Vienna, Austria [Rev Urol. 2010;12(2/3):e125-e128 doi: 10.3909/riu0491]

Prostate cancer screening Bladder cancer Renal cancer Robotics Cancer mortality rates

Volume 12, Number 1 Review Articles

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience

Treatment Update

Helen Sadri Julia Finkelstein Herbert Lepor Elisabeth Eckersberger Bob Djavan Samir S Taneja

Open radical prostatectomy (ORP) is the reference standard for the surgical management of localized prostate cancer. With wider availability of minimally invasive radical prostatectomy techniques, there is a debate regarding the standard treatment of the management of localized prostate cancer. Therefore, we reviewed the current status of laparoscopic radical prostatectomy (LRP) and robotic-assisted laparoscopic radical prostatectomy (RALRP) as compared with ORP. Because no prospective, randomized trials comparing the different techniques have been performed, outcomes must be assessed from published series by centers that focus on ORP, LRP, and RALRP. Aside from reducing the amount of blood loss, current data suggest that the most significant outcomes (cure, continence, and potency) are no better with LRP or RALRP than with conventional ORP. Therefore, in experienced hands, ORP remains the gold standard procedure. However, there is a trend toward consistently better outcomes following RALRP in comparison with LRP. In the end, individual patient outcomes can be maximized by choosing the best modality based on the patient’s comorbid medical conditions, cancer characteristics, and surgeon experience. Future studies are needed to further investigate long-term cancer control as well as functional outcomes for RALRP series.[Rev Urol. 2010;12(1):35-43 doi: 10.3909/riu0470]

Prostatic neoplasms Laparoscopy Prostatectomy Robotics